Transgenic non-human animals that express the .gamma.3 subunit of PRKAG
are described, as well as methods of using the transgenic non-human
animals as models for improving treatment, prevention, or diagnosis of
diseases related to energy metabolism, including obesity, dyslipidemia,
insulin resistance syndrome, and type 2 diabetes.
